Connection

MARY ESTES to Mice

This is a "connection" page, showing publications MARY ESTES has written about Mice.
Connection Strength

0.776
  1. Insights into human norovirus cultivation in human intestinal enteroids. mSphere. 2024 Nov 21; 9(11):e0044824.
    View in: PubMed
    Score: 0.067
  2. Phosphorylation cascade regulates the formation and maturation of rotaviral replication factories. Proc Natl Acad Sci U S A. 2018 12 18; 115(51):E12015-E12023.
    View in: PubMed
    Score: 0.044
  3. Epithelial WNT Ligands Are Essential Drivers of Intestinal Stem Cell Activation. Cell Rep. 2018 01 23; 22(4):1003-1015.
    View in: PubMed
    Score: 0.042
  4. Mapping broadly reactive norovirus genogroup I and II monoclonal antibodies. Clin Vaccine Immunol. 2015 Feb; 22(2):168-77.
    View in: PubMed
    Score: 0.034
  5. Prevention of cholestasis in the murine rotavirus-induced biliary atresia model using passive immunization and nonreplicating virus-like particles. Vaccine. 2013 Nov 19; 31(48):5778-84.
    View in: PubMed
    Score: 0.031
  6. Autophagy hijacked through viroporin-activated calcium/calmodulin-dependent kinase kinase-? signaling is required for rotavirus replication. Proc Natl Acad Sci U S A. 2012 Dec 11; 109(50):E3405-13.
    View in: PubMed
    Score: 0.029
  7. Osteopontin upregulation in rotavirus-induced murine biliary atresia requires replicating virus but is not necessary for development of biliary atresia. Virology. 2011 Sep 01; 417(2):281-92.
    View in: PubMed
    Score: 0.027
  8. Norwalk virus does not replicate in human macrophages or dendritic cells derived from the peripheral blood of susceptible humans. Virology. 2010 Oct 10; 406(1):1-11.
    View in: PubMed
    Score: 0.025
  9. Rotavirus enterotoxin NSP4 has mucosal adjuvant properties. Vaccine. 2010 Apr 19; 28(18):3106-11.
    View in: PubMed
    Score: 0.024
  10. Epitope mapping and use of epitope-specific antisera to characterize the VP5* binding site in rotavirus SA11 NSP4. Virology. 2008 Mar 30; 373(1):211-28.
    View in: PubMed
    Score: 0.021
  11. Rotavirus viremia and extraintestinal viral infection in the neonatal rat model. J Virol. 2006 May; 80(10):4820-32.
    View in: PubMed
    Score: 0.019
  12. High efficiency cross-reactive monoclonal antibody production by oral immunization with recombinant norwalk virus-like particles. Microbiol Immunol. 2006; 50(11):883-8.
    View in: PubMed
    Score: 0.018
  13. Loss of mucin 2 and MHC II molecules causes rare resistance to murine RV infection. J Virol. 2025 Feb 25; 99(2):e0150724.
    View in: PubMed
    Score: 0.017
  14. Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice. Vaccine. 2003 Sep 08; 21(25-26):3885-900.
    View in: PubMed
    Score: 0.015
  15. Hepatobiliary organoids derived from leporids support the replication of hepatotropic lagoviruses. J Gen Virol. 2023 08; 104(8).
    View in: PubMed
    Score: 0.015
  16. A DLG1-ARHGAP31-CDC42 axis is essential for the intestinal stem cell response to fluctuating niche Wnt signaling. Cell Stem Cell. 2023 02 02; 30(2):188-206.e6.
    View in: PubMed
    Score: 0.015
  17. Norwalk virus-like particle hemagglutination by binding to h histo-blood group antigens. J Virol. 2003 Jan; 77(1):405-15.
    View in: PubMed
    Score: 0.015
  18. Cross-reactivity among several recombinant calicivirus virus-like particles (VLPs) with monoclonal antibodies obtained from mice immunized orally with one type of VLP. J Clin Microbiol. 2002 Jul; 40(7):2459-65.
    View in: PubMed
    Score: 0.014
  19. VLA-2 (alpha2beta1) integrin promotes rotavirus entry into cells but is not necessary for rotavirus attachment. J Virol. 2002 Feb; 76(3):1109-23.
    View in: PubMed
    Score: 0.014
  20. Single-cell sequencing of rotavirus-infected intestinal epithelium reveals cell-type specific epithelial repair and tuft cell infection. Proc Natl Acad Sci U S A. 2021 11 09; 118(45).
    View in: PubMed
    Score: 0.014
  21. Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses. J Virol. 2001 Oct; 75(20):9713-22.
    View in: PubMed
    Score: 0.013
  22. Interactions between rotavirus and gastrointestinal cells. Curr Opin Microbiol. 2001 Aug; 4(4):435-41.
    View in: PubMed
    Score: 0.013
  23. Telomere dysfunction instigates inflammation in inflammatory bowel disease. Proc Natl Acad Sci U S A. 2021 07 20; 118(29).
    View in: PubMed
    Score: 0.013
  24. A functional NSP4 enterotoxin peptide secreted from rotavirus-infected cells. J Virol. 2000 Dec; 74(24):11663-70.
    View in: PubMed
    Score: 0.013
  25. Rotavirus induces intercellular calcium waves through ADP signaling. Science. 2020 11 20; 370(6519).
    View in: PubMed
    Score: 0.013
  26. Telomere dysfunction activates YAP1 to drive tissue inflammation. Nat Commun. 2020 09 21; 11(1):4766.
    View in: PubMed
    Score: 0.013
  27. CD300lf is the primary physiologic receptor of murine norovirus but not human norovirus. PLoS Pathog. 2020 04; 16(4):e1008242.
    View in: PubMed
    Score: 0.012
  28. NSP4 elicits age-dependent diarrhea and Ca(2+)mediated I(-) influx into intestinal crypts of CF mice. Am J Physiol. 1999 08; 277(2):G431-44.
    View in: PubMed
    Score: 0.012
  29. A viral enterotoxin. A new mechanism of virus-induced pathogenesis. Adv Exp Med Biol. 1999; 473:73-82.
    View in: PubMed
    Score: 0.011
  30. Mutations in rotavirus nonstructural glycoprotein NSP4 are associated with altered virus virulence. J Virol. 1998 May; 72(5):3666-72.
    View in: PubMed
    Score: 0.011
  31. Oral immunization with recombinant Norwalk virus-like particles induces a systemic and mucosal immune response in mice. J Virol. 1998 Feb; 72(2):1345-53.
    View in: PubMed
    Score: 0.010
  32. Virus-like particle vaccines for mucosal immunization. Adv Exp Med Biol. 1997; 412:387-95.
    View in: PubMed
    Score: 0.010
  33. Virus-like particles as a rotavirus subunit vaccine. J Infect Dis. 1996 Sep; 174 Suppl 1:S88-92.
    View in: PubMed
    Score: 0.009
  34. Age-dependent diarrhea induced by a rotaviral nonstructural glycoprotein. Science. 1996 Apr 05; 272(5258):101-4.
    View in: PubMed
    Score: 0.009
  35. Antigenic mapping of the recombinant Norwalk virus capsid protein using monoclonal antibodies. Virology. 1996 Mar 01; 217(1):252-61.
    View in: PubMed
    Score: 0.009
  36. Rotavirus subunit vaccines. Arch Virol Suppl. 1996; 12:199-206.
    View in: PubMed
    Score: 0.009
  37. Viral infection. Prevention and cure of rotavirus infection via TLR5/NLRC4-mediated production of IL-22 and IL-18. Science. 2014 Nov 14; 346(6211):861-5.
    View in: PubMed
    Score: 0.008
  38. Comparative growth of different rotavirus strains in differentiated cells (MA104, HepG2, and CaCo-2). Virology. 1991 Oct; 184(2):729-37.
    View in: PubMed
    Score: 0.007
  39. Golgi localization of ERManI defines spatial separation of the mammalian glycoprotein quality control system. Mol Biol Cell. 2011 Aug 15; 22(16):2810-22.
    View in: PubMed
    Score: 0.007
  40. Characterization of monoclonal antibodies to human group B rotavirus and their use in an antigen detection enzyme-linked immunosorbent assay. J Clin Microbiol. 1989 Feb; 27(2):245-50.
    View in: PubMed
    Score: 0.006
  41. Integrins alpha1beta1 and alpha2beta1 are receptors for the rotavirus enterotoxin. Proc Natl Acad Sci U S A. 2008 Jul 01; 105(26):8811-8.
    View in: PubMed
    Score: 0.005
  42. Differential requirements for T cells in viruslike particle- and rotavirus-induced protective immunity. J Virol. 2008 Mar; 82(6):3135-8.
    View in: PubMed
    Score: 0.005
  43. Tomato is a highly effective vehicle for expression and oral immunization with Norwalk virus capsid protein. Plant Biotechnol J. 2006 Jul; 4(4):419-32.
    View in: PubMed
    Score: 0.005
  44. Ricin toxin B subunit enhancement of rotavirus NSP4 immunogenicity in mice. Viral Immunol. 2006; 19(1):54-63.
    View in: PubMed
    Score: 0.005
  45. Oral immunization with a shiga toxin B subunit: rotavirus NSP4(90) fusion protein protects mice against gastroenteritis. Vaccine. 2005 Oct 25; 23(44):5168-76.
    View in: PubMed
    Score: 0.004
  46. Mucosal immunization with a ricin toxin B subunit-rotavirus NSP4 fusion protein stimulates a Th1 lymphocyte response. J Biotechnol. 2006 Jan 24; 121(2):272-83.
    View in: PubMed
    Score: 0.004
  47. Host, viral, and vaccine factors that determine protective efficacy induced by rotavirus and virus-like particles (VLPs). Vaccine. 2006 Feb 20; 24(8):1170-9.
    View in: PubMed
    Score: 0.004
  48. Intestinal TSH production is localized in crypt enterocytes and in villus 'hotblocks' and is coupled to IL-7 production: evidence for involvement of TSH during acute enteric virus infection. Immunol Lett. 2005 Jun 15; 99(1):36-44.
    View in: PubMed
    Score: 0.004
  49. The VP7 outer capsid protein of rotavirus induces polyclonal B-cell activation. J Virol. 2004 Jul; 78(13):6974-81.
    View in: PubMed
    Score: 0.004
  50. Interaction(s) of rotavirus non-structural protein 4 (NSP4) C-terminal peptides with model membranes. Biochem J. 2004 Jun 15; 380(Pt 3):723-33.
    View in: PubMed
    Score: 0.004
  51. Rotavirus antigenaemia and viraemia: a common event? Lancet. 2003 Nov 01; 362(9394):1445-9.
    View in: PubMed
    Score: 0.004
  52. Initial interaction of rotavirus strains with N-acetylneuraminic (sialic) acid residues on the cell surface correlates with VP4 genotype, not species of origin. J Virol. 2002 Apr; 76(8):4087-95.
    View in: PubMed
    Score: 0.003
  53. Heterotypic protection and induction of a broad heterotypic neutralization response by rotavirus-like particles. J Virol. 1999 Jun; 73(6):4813-22.
    View in: PubMed
    Score: 0.003
  54. Rotavirus disease, but not infection and development of intestinal histopathological lesions, is age restricted in rabbits. Virology. 1998 Nov 25; 251(2):343-60.
    View in: PubMed
    Score: 0.003
  55. Rotavirus 2/6 viruslike particles administered intranasally with cholera toxin, Escherichia coli heat-labile toxin (LT), and LT-R192G induce protection from rotavirus challenge. J Virol. 1998 Apr; 72(4):3390-3.
    View in: PubMed
    Score: 0.003
  56. Rotavirus virus-like particles administered mucosally induce protective immunity. J Virol. 1997 Nov; 71(11):8707-17.
    View in: PubMed
    Score: 0.003
  57. The rotavirus enterotoxin NSP4 mobilizes intracellular calcium in human intestinal cells by stimulating phospholipase C-mediated inositol 1,4,5-trisphosphate production. Proc Natl Acad Sci U S A. 1997 Apr 15; 94(8):3960-5.
    View in: PubMed
    Score: 0.002
  58. Recombinant Norwalk virus-like particles as an oral vaccine. Arch Virol Suppl. 1996; 12:243-9.
    View in: PubMed
    Score: 0.002
  59. Specific interactions between rotavirus outer capsid proteins VP4 and VP7 determine expression of a cross-reactive, neutralizing VP4-specific epitope. J Virol. 1992 Jan; 66(1):432-9.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.